| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Molecular Medicine |
From the Division of Cardiology, Department of Medicine (B.H.J., Y.C.P., B.Q., A.H., F.A.K., Y.-X.L., K.I.) and Department of Anesthesiology (G.G., A.R.W., D.E.B.), Johns Hopkins University School of Medicine, Baltimore, Md; Departments of Physiology (B.H.J.) and Pathology (J.-M.K.), Chungnam National University, Daejon, South Korea; Department of Microbiology and Immunology (Y.C.P.), Pusan National University, South Korea; and Department of Surgery (M.O.), Hokkaido University, Sapporo, Japan.
Correspondence to Kaikobad Irani, Department of Medicine, Johns Hopkins University, Ross 1023, 720 Rutland Ave, Baltimore, MD 21214. E-mail kirani{at}jhmi.edu
The dual-function protein apurinic/apyrmidinic endonuclease/redox factor-1 (APE1/ref-1) is essential for DNA repair and also governs the reductive activation of many redox-sensitive transcription factors. We examined the role of APE1/ref-1 in regulation of endothelium-dependent tone and systemic blood pressure. APE1/ref-1+/ mice have impaired endothelium-dependent vasorelaxation, reduced vascular NO levels, and are hypertensive. APE1/ref-1 upregulates H-ras expression and leads to H-ras-mediated, phosphoinositide-3 kinase/Akt kinase-dependent calcium sensitization of endothelial NO synthase (eNOS), stimulating NO production. The reducing property of APE1/ref-1 is essential for upregulation of H-ras and for the calcium sensitization of eNOS. These findings uncover a novel physiological role for APE1/ref-1 in regulating vascular tone by governance of eNOS activity and bioavailable NO.
Key Words: eNOS redox hypertension H-ras
Related Article:
Circ. Res. 2004 95: 849-851.
This article has been cited by other articles:
![]() |
G. Tell, D. M. Wilson III, and C. H. Lee Intrusion of a DNA Repair Protein in the RNome World: Is This the Beginning of a New Era? Mol. Cell. Biol., January 15, 2010; 30(2): 366 - 371. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Lee, B. H. Jeon, K.-J. Won, C.-K. Lee, T.-K. Park, W. S. Choi, Y. M. Bae, H. S. Kim, S. K. Lee, S. H. Park, et al. Gene Transfer of Redox Factor-1 Inhibits Neointimal Formation: Involvement of Platelet-Derived Growth Factor-{beta} Receptor Signaling via the Inhibition of the Reactive Oxygen Species-Mediated Syk Pathway Circ. Res., January 30, 2009; 104(2): 219 - 227. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Kim, S.-B. Jung, A. Naqvi, T. A. Hoffman, J. DeRicco, T. Yamamori, M. P. Cole, B.-H. Jeon, and K. Irani P53 Impairs Endothelium-Dependent Vasomotor Function Through Transcriptional Upregulation of P66shc Circ. Res., December 5, 2008; 103(12): 1441 - 1450. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. R. Ansari, A. Nadeem, M. A. H. Talukder, S. Sakhalkar, and S. J. Mustafa Evidence for the involvement of nitric oxide in A2B receptor-mediated vasorelaxation of mouse aorta Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H719 - H725. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Kim, S. J. Son, E. K. Kim, S. N. Kim, D. G. Yoo, H. S. Kim, S. W. Ryoo, S. D. Lee, K. Irani, and B. H. Jeon Apurinic/apyrimidinic endonuclease1/redox factor-1 inhibits monocyte adhesion in endothelial cells Cardiovasc Res, February 1, 2006; 69(2): 520 - 526. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Liu, R. Colavitti, I. I. Rovira, and T. Finkel Redox-Dependent Transcriptional Regulation Circ. Res., November 11, 2005; 97(10): 967 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Patterson Blood Pressure Control Goes Nuclear Circ. Res., October 29, 2004; 95(9): 849 - 851. [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |